scleroderma

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
Anna-Maria Hoffmann-Vold, Yannick Allanore, Margarida Alves, Cathrine Brunborg, Paolo Airó, Lidia P Ananieva, László Czirják, Serena Guiducci, Eric Hachulla, Mengtao Li, Carina Mihai, Gabriela Riemekasten, Petros P Sfikakis, Otylia Kowal-Bielecka, Antonella Riccardi, Oliver Distler

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-217455; DOI: 10.1136/annrheumdis-2020-217455
COVID-19 in Italian patients with rheumatic autoimmune systemic diseases
Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, Poupak Fallahi, Alessandro Antonelli

Annals of the Rheumatic Diseases Oct 2020, annrheumdis-2020-219113; DOI: 10.1136/annrheumdis-2020-219113
Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement
Kimberly Showalter, Robert Spiera, Cynthia Magro, Phaedra Agius, Viktor Martyanov, Jennifer M Franks, Roshan Sharma, Heather Geiger, Tammara A Wood, Yaxia Zhang, Caryn R Hale, Jackie Finik, Michael L Whitfield, Dana E Orange, Jessica K Gordon

Annals of the Rheumatic Diseases Oct 2020, annrheumdis-2020-217840; DOI: 10.1136/annrheumdis-2020-217840
Correspondence on ‘Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial’
Markus Bredemeier

Annals of the Rheumatic Diseases Oct 2020, annrheumdis-2020-218911; DOI: 10.1136/annrheumdis-2020-218911
Response to: ‘Correspondence on ‘Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial’’ by Bredemeier
James R Seibold, Veronika Kohlbrenner, Margarida Alves, Oliver Distler

Annals of the Rheumatic Diseases Oct 2020, annrheumdis-2020-218960; DOI: 10.1136/annrheumdis-2020-218960
Genomic Risk Score impact on susceptibility to systemic sclerosis
Lara Bossini-Castillo, Gonzalo Villanueva-Martin, Martin Kerick, Marialbert Acosta-Herrera, Elena López-Isac, Carmen P Simeón, Norberto Ortego-Centeno, Shervin Assassi, International SSc Group, Australian Scleroderma Interest Group (ASIG), PRECISESADS Clinical Consortium, PRECISESADS Flow Cytometry study group, Nicolas Hunzelmann, Armando Gabrielli, J K de Vries-Bouwstra, Yannick Allanore, Carmen Fonseca, Christopher P Denton, Timothy RDJ Radstake, Marta Eugenia Alarcón-Riquelme, Lorenzo Beretta, Maureen D Mayes, Javier Martin

Annals of the Rheumatic Diseases Oct 2020, annrheumdis-2020-218558; DOI: 10.1136/annrheumdis-2020-218558
A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis
Yannick Allanore, Peter Wung, Christina Soubrane, Corinne Esperet, Frederic Marrache, Raphael Bejuit, Amel Lahmar, Dinesh Khanna, Christopher P Denton

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218447; DOI: 10.1136/annrheumdis-2020-218447
Response to: ‘Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic’ by Santos-Moreno et al
Emanuele Bozzalla Cassione, Giovanni Zanframundo, Alessandro Biglia, Veronica Codullo, Carlomaurizio Montecucco, Lorenzo Cavagna

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-218193; DOI: 10.1136/annrheumdis-2020-218193
Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab
Jérôme Avouac, Paolo Airó, Nicolas Carlier, Marco Matucci-Cerinic, Yannick Allanore

Annals of the Rheumatic Diseases Jun 2020, annrheumdis-2020-217864; DOI: 10.1136/annrheumdis-2020-217864
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management
Marco Matucci-Cerinic, Cosimo Bruni, Yannick Allanore, Massimo Clementi, Lorenzo Dagna, Nemanja S Damjanov, Amato de Paulis, Christopher P Denton, Oliver Distler, David Fox, Daniel E Furst, Dinesh Khanna, Thomas Krieg, Masataka Kuwana, Eun Bong Lee, Mengtao Li, Shiv Pillai, Yukai Wang, Xiaofeng Zeng, Gloria Taliani

Annals of the Rheumatic Diseases Jun 2020, 79 (6) 724-726; DOI: 10.1136/annrheumdis-2020-217407

Main menu

scleroderma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

scleroderma

Pages